Which COVID-19 vaccination is right for you?

Find the age bracket for the person you are scheduling an appointment for to learn more about COVID-19

vaccinations details, including immuno-compromised individuals. You can find additional information from the

CDC about vaccine recommendations for immuno-compromised individuals here and general

recommendations here.

Non - Immunocompromised

Pfizer


Primary Series: 2 doses, 21 days apart
Boosters: Not recommended yet
Additional Doses: Not recommended yet
Maximum Doses: 2

Moderna


Primary Series: Not yet approved
Boosters: N/A
Additional Doses: N/A
Maximum Doses: 0

Johnson & Johnson

 

Primary Series: Not yet approved
Boosters: N/A
Additional Doses: N/A
Maximum Doses: 0

Immunocompromised

Pfizer


Primary Series: 2 doses, 21 days apart
Additional Doses: 1 dose, 28 days after completion of primary series
Boosters: Not recommended yet
Maximum Doses: 3

Moderna


Primary Series: Not yet approved
Boosters: N/A
Additional Doses: N/A
Maximum Doses: 0

Johnson & Johnson
 

Primary Series: Not yet approved
Additional Doses: N/A
Boosters: N/A
Maximum Doses: 0

Non - Immunocompromised

Pfizer


Primary Series: 2 doses, 21 days apart
Boosters: Not recommended yet
Additional Doses: Not recommended yet
Maximum Doses: 2

Moderna


Primary Series: Not yet approved
Boosters: N/A
Additional Doses: N/A
Maximum Doses: 0

Johnson & Johnson


Primary Series: Not yet approved
Boosters: N/A
Additional Doses: N/A
Maximum Doses: 0

Immunocompromised

Pfizer


Primary Series: 2 doses, 21 days apart
Additional Doses: 1 dose, 28 days after completion of primary series

Boosters: Not recommended yet
Maximum Doses: 3

Moderna


Primary Series: Not yet approved
Additional Doses: N/A
Boosters: N/A
Maximum Doses: 0

Johnson & Johnson


Primary Series: Not yet approved
Additional Doses: N/A
Boosters: N/A
Maximum Doses: 0

Non - Immunocompromised

Pfizer


Primary Series: 2 doses, 21 days apart
Boosters: 5 months after completion of primary series

Additional Doses: Not recommended yet

Maximum Doses: 3

Moderna


Primary Series: Not yet approved
Boosters: N/A
Additional Doses: N/A
Maximum Doses: 0

Johnson & Johnson

 

Primary Series: Not yet approved
Boosters: N/A
Additional Doses: N/A
Maximum Doses: 0

Immunocompromised

Pfizer


Primary Series: 2 doses, 21 days apart
Additional Doses: 28 days after completion of primary series

Boosters: 3 months after dose 3
Maximum Doses: 4

Moderna


Primary Series: Not yet approved
Additional Doses: N/A
Boosters: N/A
Maximum Doses: 0

Johnson & Johnson


Primary Series: Not yet approved
Additional Doses: N/A
Boosters: N/A
Maximum Doses: 0

Non - Immunocompromised

Pfizer


Primary Series: 2 doses, 21 days to 8 weeks apart
Boosters: 5 months after Pfizer/Moderna primary series

2 months after Johnson and Johnson primary series

Additional Doses: Not recommended yet
Maximum Doses: 3

Moderna


Primary Series: 2 doses, 28 days to 8 weeks apart
Boosters: 5 months after Pfizer/Moderna primary series

2 months after Johnson and Johnson primary series

Additional Doses: Not recommended yet
Maximum Doses: 3

Johnson & Johnson


Primary Series: 1 dose
Boosters: 2 months after primary series of Johnson & Johnson

Second Booster: 4 months after first booster
Maximum Doses: 3

Immunocompromised

Pfizer


Primary Series: 2 doses, 21 days apart
Additional Doses: 28 days after completion of primary series

Boosters: 3 months after additional dose
Second Booster: 4 months after first booster, can only be Pfizer or Moderna

Maximum Doses: 5

Moderna


Primary Series: 2 doses, 28 days apart
Additional Doses: 28 days after completion of primary series

Boosters: 3 months after additional dose
Second Booster: 4 months after first booster, can only be Pfizer or Moderna

Maximum Doses: 5

Johnson & Johnson


Primary Series: 1 dose
Additional Doses: 28 days after completion of primary series

Boosters: 2 months after additional dose
Second Booster: 4 months after first booster, can only be Pfizer or Moderna

Maximum Doses: 4

Non - Immunocompromised

Pfizer


Primary Series: Ages 50-64 - 2 doses, 21 days to 8 weeks apart

Ages 65+ - 2 doses, 21 days apart

Boosters: 5 months after Pfizer/Moderna primary series

2 months after Johnson and Johnson primary series

Second Booster: 4 months after first booster, can only be Pfizer/Moderna

Maximum Doses: 4

Moderna


Primary Series: Ages 50-64 - 2 doses, 28 days to 8 weeks apart

Ages 65+ - 2 doses, 28 days apart

Boosters: 5 months after Pfizer/Moderna primary series

2 months after Johnson and Johnson primary series
Second Booster: 4 months after first booster, can only be Pfizer/Moderna

Maximum Doses: 4

Johnson & Johnson


Primary Series: 1 dose
Boosters: 2 months after primary series of Johnson & Johnson

Second Booster: 4 months after first booster, can only be Pfizer/Moderna

Maximum Doses: 3

Immunocompromised

Pfizer


Primary Series: 2 doses, 21 days apart
Additional Doses: 28 days after completion of primary series

Boosters: 3 months after additional dose
Second Booster: 4 months after first booster
Maximum Doses: 5

Moderna


Primary Series: 2 doses, 28 days apart
Additional Doses: 28 days after completion of primary series

Boosters: 3 months after additional dose
Second Booster: 4 months after first booster
Maximum Doses: 5

Johnson & Johnson


Primary Series: 1 dose
Additional Doses: 28 days after completion of primary series

Boosters: 2 months after additional dose
Second Booster: 4 months after first booster
Maximum Doses: 4

Eligible COVID-19 Vaccinations in the U.S.

According to the CDC, a customer who has received a complete primary series of a World Health Organization (WHO) approved COVID-19 vaccine is eligible to receive a booster of Pfizer-BioNTech. Eligible customers can receive a booster dose 5 months after the final dose in their series.

 

Need more information about the WHO approved vaccines? Learn more

 

Non-Eligible COVID-19 Vaccinations in the U.S.

A customer who has received a complete or partial (incomplete) primary series of any COVID-19 vaccine not available in the United States or that is not approved by the World Health Organization (WHO), must start or restart their primary series with a product available in the United States.